Información de la revista
Vol. 52. Núm. 6.
Páginas 501-506 (junio 2000)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 52. Núm. 6.
Páginas 501-506 (junio 2000)
Acceso a texto completo
Correlación entre carga viral elevada y concentraciones de TNF-α y cICAM-1 en el plasma de niños infectados por el VIH-1
Relationship between high plasma viral load and levels of tnf-a and cicam-1 in vertically hiv-1 infected children
Visitas
6440
S. Resinoa, J.L. Jiméneza, J.M. Bellóna, D. Gurbindob, M.A. Muñoz-Fernándeza,
Autor para correspondencia
Mmunoz@cbm.uam.es

Correspondencia: Hospital General Universitario Gregorio Marañón. División de Inmunología. Dr. Esquerdo, 46. 28007 Madrid
a Secciones de Inmunología Hospital General Universitario Gregorio Marañón. Madrid.
b Inmuno-Pediatría. Hospital General Universitario Gregorio Marañón. Madrid.
Este artículo ha recibido
Información del artículo
Resumen
Bibliografía
Descargar PDF
Estadísticas
Objetivo

Analizar si existe relación entre los valores plasmáticos del factor de necrosis tumoral (TNF-α) y la molécula de adhesión intercelular circulante tipo 1 (cICAM-1) con valores de carga viral plasmática (CV) en niños infectados verticalmente por el VIH.

Pacientes y métodos

Estudiamos 44 niños VIH-1 y un grupo control de 38 niños no infectados por el VIH-1. Las subpoblaciones celulares se realizaron por citometría de flujo, las concentraciones de TNF-α y cICAM-1 se cuantificaron por técnicas de enzimoinmunoanálisis y la CV se cuantificó mediante un análisis molecular estándar comercial.

Resultados

Los niños infectados por el VIH-1 presentaron valores significativamente más altos de TNF-α y cICAM-1 que los niños del grupo control. Dividimos a los niños VIH-1 según los valores de CV. Los niños VIH-1 con CV mayor de 50.000 copias/ml produjeron más TNF-α (12,83; IC del 95%: 24,71-0,95 pg/ml) y cICAM-1 (248,94; IC del 95%: 419,01-78,84 ng/ml) que los niños VIH-1 con CV inferior a 50.000 copias/ml, de tal forma que se producía un incremento de 6,57 pg/ml de TNF-α y de 119,97 ng/ml de cICAM-1 por cada log10 de CV.

Conclusiones

Nuestros datos indican que a medida que en el plasma de los niños VIH-1 se incrementan los valores de CV también se incrementan los valores de TNF-α y cICAM-1.

Palabras clave:
VIH
Niños
Carga viral
TNF-α
cICAM-1
Objective

To assess the relationship among plasma TNF-α and cICAM-1 levels and plasma viral load (VL) in HIV-infected children and to compare these values with those of healthy non-HIV infected children.

Patients and methods

We studied 44 HIV-infected children and 38 non-HIV-infected children. The VL was quantified using standard molecular assay. CD4 and CD8 lymphocyte subpopulations were determined by flow cytometry. TNF-α and cICAM-1 were quantified using commercially available specific enzyme-linked immunosorbent assay (ELISA).

Results

Levels of TNF-α and cICAM-1 were higher in HIV-infect-ed children than in non-HIV infected children. HIV-infected children with VL > 50000 copies/ml had higher levels of TNF-α (12.83; 95% CI: 24.71 to 0.95 pg/ml) and cICAM-1 (248.94; 95% CI: 419.01 to 78.84 ng/ml) than HIV-infected children with VL < 50000 copies/ml. Interestingly, we found an increase of 6.57 pg/ml of TNF-α and 119.97 ng/ml of cICAM-1 levels for each log10 of VL.

conclusions

HIV-infected children had higher levels of TNF-α and cICAM-1 than healthy controls. Our data indicate a positive correlation among plasma TNF-a and cICAM-1 and VL levels.

Key words:
HIV
Children
Viral load
TNF-a
cICAM-1
El Texto completo está disponible en PDF
Bibliografía
[1.]
G. Pantaleo, C. Graziosi, J.F. Demarest, L. Butini, M. Montroni, C.H. Fox, et al.
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.
Nature, 362 (1993), pp. 355-358
[2.]
M. Clerici, N.I. Stocks, R.A. Zajac, R.N. Boswell, D.R. Lucey, C.S. Via, et al.
Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virusseropositive. Independence of CD4+ cell numbers and clinical stating.
J Clin Invest, 84 (1989), pp. 1892-1899
[3.]
Z. Liu, W.G. Cumberland, L.E. Hultin, H.E. Prince, R. Detels, J.V. Giorgi.
Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
J Acquir Immune Defic Syndr Hum Retrovirol, 16 (1997), pp. 83-92
[4.]
P. Aukrust, N.B. Liabakk, F. Muller, E. Lien, T. Espevik, S.S. Froland.
Serum level of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection-correlations to clinical, immunologic, and virologic parameters.
J Infect Dis, 169 (1994), pp. 420-424
[5.]
D. Hamann, P.A. Baars, M.H. Rep, B. Hooibrink, S.R. Kerkhof-Garde, M.R. Klein, et al.
Phenotypic and functional separation of memory and effector human CD8+ T cells.
J Exp Med, 186 (1997), pp. 1407-1418
[6.]
D. Israel-Biet, J. Cadranel, K. Beldjord, J.M. Andrieu, A. Jeffrey, P. Even.
Tumor necrosis factor production in HIV-seropositive subjects. Relationships with lung opportunistic infections and HIV expression in alveolar macrophages.
J Immunol, 147 (1991), pp. 490-497
[7.]
A.S. Lau, B.R. Williams.
The role of interferon and tumor necrosis factor in the pathogenesis of AIDS.
J Exp Pathol, 5 (1990), pp. 111-122
[8.]
J.F. Salazar-González, O. Martínez-Maza, N. Aziz, J.A. Kolberg, T. Yeghiazarian, L.P. Shen, et al.
Relationship of plasma HIVRNA levels and levels of TNF-alpha and immune activation products in HIVinfection.
Clin Immunol Immunopathol, 84 (1997), pp. 36-45
[9.]
S. Than, R. Hu, N. Oyaizu, J. Romano, X. Wang, S. Sheikh, et al.
Cytokine pattern in relation to disease progression in human immunodeficiency virus-infected children.
J Infect Dis, 175 (1997), pp. 47-56
[10.]
E. Obregón, C. Börner, J. Navarro, M.D. Gurbindo, E. Fernández-Cruz, M.A. Muñoz-Fernández.
Elevated leels of circulating intercellular adhesion molecule 1 and tumor necrosis factor a in the serum of children vertically infection with HIV-1. Pediatric AIDS and HIV Infection.
Fetus and adolescent, 7 (1996), pp. 413-417
[11.]
C.C. Brown, G. Poli, N. Lubaki, M. St. Louis, F. Davachi, L. Musey, et al.
Elevated levels of tumor necrosis factor-alpha in Zairian neonate plasmas: implications for perinatal infection with the human immunodeficiency virus.
J Infect Dis, 169 (1994), pp. 975-980
[12.]
E.J. Duh, W.J. Maury, T.M. Folks, A.S. Fauci, A.B. Rabson.
Tumor necrosis factor alpha activates human immunodeficiency virus type 1 throughinduction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.
Am J Obstet Gynecol, 161 (1989), pp. 501-502
[13.]
M.A. Muñoz-Fernández, J. Navarro, A. García, C. Punzón, E. Fernández-Cruz, M. Fresno.
Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-kappa B activation.
J Allergy Clin Immunol, 100 (1997), pp. 838-845
[14.]
A. Vyakarman, J. McKeating, A. Meager, P.C. Beverley.
Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication.
Aids, 4 (1990), pp. 21-27
[15.]
M.P. Bevilacqua.
Endothelial-leukocyte adhesion molecules.
Annu Rev Immunol, 11 (1993), pp. 767-804
[16.]
C.A. Dinarello.
Biologic basis for interleukin-1 in disease.
Blood, 87 (1996), pp. 2096-2147
[17.]
F. Puppo, S. Brenci, M. Scudeletti, L. Lanza, O. Bosco, F. Indiveri.
Elevated serum levels of circulating intercellular adhesion molecule-1 in HIV infection.
Aids, 7 (1993), pp. 593-594
[18.]
J. Most, R. Zangerle, M. Herold, D. Fuchs, H. Wachter, P. Fritsch, et al.
Elevated concentrations of circulating intercellular adhesion molecule 1 (ICAM-1) inHIV-1 infection.
J Acquir Immune Defic Syndr, 6 (1993), pp. 221-226
[19.]
M. Tsujisaki, K. Imai, H. Hirata, Y. Hanzawa, J. Masuya, T. Nakano, et al.
Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases.
Clin Exp Immunol, 85 (1991), pp. 3-8
[20.]
M.A. Muñoz-Fernández, E. Obregón, J. Navarro, C. Borner, M.D. Gurbindo, T.H. Sampelayo.
Relationship of virologic, immunologic and clinical parameters in infants with vertically acquired humanimmunodeficiency virus type 1 infection.
Pediatr Res, 40 (1996), pp. 597-602
[21.]
CDCP..
Center for Diseases Control Prevention. Revised classification systemfor HIV-1 infection in children less than 13 years of age.
Mmwr, 43 (1994), pp. 1-13
[22.]
S. Resino, J.L. Jiménez, D. Gurbindo, M.A. Muñoz-Fernández.
Marcadores predictivos de supervivencia en niños menores de 12 meses de edad infectados verticalmente por el virus de la inmunodeficiencia humana.
Med Clin (Barc), 113 (1999), pp. 561-566
[23.]
G. Poli, A. Kinter, J.S. Justement, J.H. Kehrl, P. Bressler, S. Stanley, et al.
Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression.
Proc Natl Acad Sci USA, 87 (1990), pp. 782-795
[24.]
G. Herbein, S. Keshav, M. Collin, L.J. Montaner, S. Gordon.
HIV-1 induces tumour necrosis factor and IL-1 gene expression in-primary human macrophages independent of productive infection.
Clin Exp Immunol, 95 (1994), pp. 442-449
[25.]
K. Hestdal, P. Aukrust, F. Muller, E. Lien, V. Bjerkeli, T. Espevik, et al.
Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load.
Pediatr Infec Dis J, 16 (1997), pp. 963-967
[26.]
L. Monno, G.B. Zimatore, M. Di Stefano, A. Appice, P. Livrea, G. Angarano.
Reduced concentrations of HIV-RNA and TNF-alpha coexist in CSF of AIDS patients with progressive multifocal leukoencephalopathy.
J Neurol Neurosurg Psychiatry, 67 (1999), pp. 369-373
[27.]
L.M. Mofenson, J. Korelitz, W.A. Meyer 3rd, J. Bethel, K. Rich, S. Pahwa, et al.
The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development IntravenousImmunoglobulinClinical Trial Study Group.
J Infect Dis, 175 (1997), pp. 1029-1038
[28.]
S. Resino, M.D. Gurbindo, J.M. Bellón, S. Sánchez-Ramón, M.A. Muñoz-Fernández.
Predictive markers of clinical outcome in vertically HIV-1 infected infants, a prospective longitudinal study.
Pediatr Res, 47 (2000), pp. 1-7
[29.]
G. Poli, A. Fauci.
Role of cytokines in the pathogenesis of human immunodeficiency virus infection.
Human cytokines: their role in disease and therapy, pp. 421-449
[30.]
T. Matsuyama, N. Kobayashi, N. Yamamoto.
Cytokines and HIV infection: is Aids a tumor necrosis factor disease?.
Aids, 5 (1991), pp. 1405-1417
[31.]
Resino S, Muñoz-Fernández MA. Marcadores predictivos de evolución de la infección pediátrica por el virus de la inmunodeficiencia humana tipo 1. Acta Pediatr Esp 2000 (en prensa).
[32.]
M. Feldmann, M.J. Elliott, J.N. Woody, R.N. Maini.
Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
Adv Immunol, 64 (1997), pp. 283-350
[33.]
D.M. Meyer, M.L. Dustin, C.P. Carron.
Characterization of intercellular adhesion molecule-1 ectodomain (sICAM-1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1.
J Immunol, 155 (1995), pp. 3578-3584
Copyright © 2000. Asociación Española de Pediatría
Descargar PDF
Idiomas
Anales de Pediatría
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?